Imago BioSciences, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2021 to Q1 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: Imago BioSciences, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2022.
Imago BioSciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$11.5M, a 63.3% decline year-over-year.
Imago BioSciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$39.8M, a 135% decline from 2020.

Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2022		-$11.5M	-$4.47M	-63.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-12
Q1 2021		-$7.05M			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.